Prostate-Specific Membrane Antigen: The Target of the Decade, from Biochemical Recurrence to Widespread Adoption (perspective on “Evaluation of hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy” J Nucl Med. 2015;56:668–674)
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.